Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
CorneaGen logo — company profile

CorneaGen

Founded 2016 United States Seattle, United States 155 employees Series B Total: $77.00M Biotechnology, Health Care +2

General Information

Company Name CorneaGen
Founded Year 2016
Location United States Seattle, United States
Founders / Decision Makers
Team member
Employees 155
Industries Biotechnology, Health Care, Health and Wellness +1
Funding Stage Series B
Social

BounceWatch is an independent company data service, not affiliated with CorneaGen. To contact CorneaGen, visit corneagen.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does CorneaGen compare?

A PDF of CorneaGen and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting CorneaGen soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About CorneaGen

CorneaGen is a U.S.-based biotechnology and healthcare startup founded in 2016. The company's mission is to revolutionize the treatment and care of corneal disease by providing top-quality donor tissue, exceptional customer service, and cutting-edge products. With a focus on continuous innovation in tissue processing technology and surgical devices, CorneaGen also advocates for patient access and simplified payer reimbursement policies. As the world's leading eye bank with multiple locations and local partnerships throughout the U.S., CorneaGen has made a significant impact by gifting the invaluable sense of sight to tens of thousands of people annually. On 10 July 2019, CorneaGen secured a notable $37.00M Series B investment from Falcon Vision, Flying L Partners, and Petrichor Healthcare. This substantial investment underscores the confidence of these seasoned investors in the potential and vision of CorneaGen and its endeavors. The funding is likely to bolster the company's efforts to further advance cornea care, drive innovation, and expand its reach, ultimately underlining its commitment to transforming the field of ophthalmology and healthcare.

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Debt Financing $25.00M 1
Petrichor Healthcare Capital Management
10 Jul 2019
Series B $37.00M 3
Falcon Vision Flying L Partners
Falcon Vision, Flying L Partners +1
10 Jul 2019
Series A $5.00M -
19 Apr 2018
Series A $10.00M 2
Flying L Partners Visionary Ventures
Flying L Partners, Visionary Ventures
18 Oct 2016

FAQ About CorneaGen

CorneaGen’s mission is to provide the highest quality donor tissue, unparalleled customer service and superior products that transform how ophthalmologists treat and care for every person impacted by corneal disease. Through continuous innovations in tissue processing technology and surgical devices...
CorneaGen was founded in 2016.
CorneaGen is headquartered in Seattle, United States.
CorneaGen operates in Biotechnology, Health Care, Health and Wellness and Medical Devices.
CorneaGen has approximately 155 employees.
CorneaGen has completed 4 funding rounds, raising a total of $77.00M. The latest funding stage is Series B.

We're actively collecting intelligence on CorneaGen.

Source: BounceWatch company record for CorneaGen, https://bouncewatch.com/company/corneagen, updated 30 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes